Skip to main

Impact case study database

The impact case study database allows you to browse and search for impact case studies submitted to the REF 2021. Use the search and filters below to find the impact case studies you are looking for.
Impact case study database FAQs
Download all impact case studies (spreadsheet)
Download all impact case studies (spreadsheet) (generating)
Download all impact case study tags (spreadsheet)
Download all impact case study tags (spreadsheet) (generating)
Back

A new standard of adjuvant care in colorectal cancer: reduced treatment burden and healthcare costs

Download case study PDF
Submitting institution
University of Glasgow
Unit of assessment
1 - Clinical Medicine
Summary impact type
Health
Request cross-referral to
-
Is this case study continued from a case study submitted in 2014?
No
Underpinning research subjects
  • Clinical Sciences
  • Oncology And Carcinogenesis
  • Public Health And Health Services

1. Summary of the impact

2. Underpinning research

3. References to the research

4. Details of the impact

5. Sources to corroborate the impact

Additional contextual information

Grant funding

Grant number Value of grant
1) G0601705 £2,707,635
2) C6716/A9894 £0
3) 14/140/84 £274,695
Countries
  • Worldwide
Formal partners
  • Mayo Clinic, Rochester, MN (USA)
  • Karmanos Cancer Institute, Wayne State University, Detroit (USA)
  • Istituto di Ricovero e Cura a Carattere Scientific, San Martino-IST, Genoa (Italy)
  • Ospedale Papa Giovanni XXIII, Bergamo (Italy)
  • IRCCS Mario Negri Institute for Pharmacological Research, Milan (Italy)
  • National Cancer Center Hospital East, Chiba (Japan)
  • Yokohama City University School of Medicine (Japan)
  • University of Oxford (UK)
  • Christie Hospital, Manchester (UK)
  • University Hospital Southampton (UK)
  • Paris Descartes University (France)
  • Sorbonne University, Paris (France)
  • National Institute of Health and Medical Research UMR1098, Besançon (France)
  • University of Crete (Greece)
  • Bioclinic Thessaloniki, Thessaloniki (Greece)
  • Dana–Farber Cancer Institute, Boston (USA)
  • Duke Cancer Institute, Durham, NC (USA)
Funding programmes
  • 1) COT- Short Course Oncology Therapy - A study of Adjuvant Chemotherapy in colorectal ca by the CACTUS & QUASAR 3 Groups
  • 2) Cancer Research UK Clinical Trials Unit - Core Programme Funding
  • 3) Extension of Follow-Up for High Risk Stage II Patients (additional 3 years) and Stage III Patients (up to year 3 follow-up) in the SCOT study
Global research identifiers
  • 1) Grid.14105.31
  • 2) Grid.11485.39
  • 3) Grid.451056.3
Name of funders
  • 1) Medical Research Council
  • 2) Cancer Research UK
  • 3) National Institute for Health Research
Researcher ORCIDs
  • 0000-0001-7367-5816
  • 0000-0002-0777-1997
  • 0000-0002-9764-0113
  • 0000-0002-3862-8798